Bioprospecting for pharmaceuticals: An overview and vision for future access and benefit sharing

4Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The vast therapeutic benefits of plants have been recognized for centuries, yet there is still a large, untapped potential for commercial medicine production. In fact, several of the most important pharmaceuticals have been based on compounds found in natural products. Bioprospecting encompasses this search for the commercial potential of medicinal natural products. The search for these drugs from nature contains unique opportunities and challenges. Within the confines of the US pharmaceutical industry, the process of drug discovery must encompass the well-being of the countries and people from which the botanical information and specimen have been obtained, while conserving plant diversity and maintaining a competitive advantage in the industry. Nature contains incredibly unique chemical compounds of unparalleled diversity, ripe for new classes of therapeutics if care can be taken to ensure the benefit for local communities, the environment, and scientists. Therefore, this chapter describes triumphs and struggles of bioprospecting and framework for the future.

Cite

CITATION STYLE

APA

Cicka, D., & Quave, C. (2019). Bioprospecting for pharmaceuticals: An overview and vision for future access and benefit sharing. In Medicinal Plants: From Farm to Pharmacy (pp. 17–34). Springer International Publishing. https://doi.org/10.1007/978-3-030-31269-5_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free